UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia

Pharmacoepidemiology and drug safety, 2024-10, Vol.33 (10), p.e70014-n/a

2024

Volltextzugriff (PDF)

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study

BMJ (Online), 2018-07, Vol.362, p.k2693

2018

Volltextzugriff (PDF)

Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events

Diabetes care, 2017-11, Vol.40 (11), p.1506-1513

2017

Volltextzugriff (PDF)

Comparative risk of infection of medications used for type 2 diabetes

Expert opinion on drug safety, 2024-09, Vol.23 (9), p.1079-1091

2024

Volltextzugriff (PDF)

The association of long‐acting insulin analogue use versus neutral protamine Hagedorn insulin use and the risk of major adverse cardiovascular events among individuals with type 2 diabetes: A population‐based cohort study

Diabetes, obesity & metabolism, 2022-11, Vol.24 (11), p.2169-2181

2022

Volltextzugriff (PDF)

Use of dipeptidyl peptidase-4 inhibitors and new-onset rheumatoid arthritis in patients with type 2 diabetes

Epidemiology (Cambridge, Mass.), 2018-11, Vol.29 (6), p.904-912

2018

Volltextzugriff (PDF)

Comparative cardiovascular and hypoglycaemic safety of glimepiride in type 2 diabetes: A population‐based cohort study

Diabetes, obesity & metabolism, 2020-02, Vol.22 (2), p.254-262

2020

Volltextzugriff (PDF)

Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Below-Knee Amputation: A Multicenter Observational Study

Diabetes care, 2020-10, Vol.43 (10), p.2444-2452

2020

Volltextzugriff (PDF)

1386-P: Dipeptidyl Peptidase-4 Inhibitors and the Risk of Skin Cancer among Patients with Type 2 Diabetes—Population-Based Cohort Study

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

SGLT‐2 inhibitors and the risk of hospitalization for community‐acquired pneumonia: A population‐based cohort study

Pharmacoepidemiology and drug safety, 2021-06, Vol.30 (6), p.740-748

2021

Volltextzugriff (PDF)

A systematic review and meta-analysis comparing outcomes between using subcutaneous insulin and continuous insulin infusion in managing adult patients with diabetic ketoacidosis

BMC endocrine disorders, 2024-08, Vol.24 (1), p.133-16, Article 133

2024

Volltextzugriff (PDF)

268-OR: The Combined Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists on the Risk of Cardiovascular Events among Patients with Type 2 Diabetes

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Long‐term clinical outcomes of oral antidiabetic drugs as fixed‐dose combinations: A nationwide retrospective cohort study

Diabetes, obesity & metabolism, 2022-10, Vol.24 (10), p.2051-2060

2022

Volltextzugriff (PDF)

Occupation as a gendered-role and outcome in systemic sclerosis

Journal of scleroderma and related disorders, 2023-06, Vol.8 (2), p.131-136

2023

Volltextzugriff (PDF)

Levothyroxine and the risk of adverse pregnancy outcomes in women with subclinical hypothyroidism: a systematic review and meta-analysis

BMC endocrine disorders, 2021-02, Vol.21 (1), p.34-34, Article 34

2021

Volltextzugriff (PDF)

Metformin and Cancer: Solutions to a Real-World Evidence Failure

Diabetes care, 2023-05, Vol.46 (5), p.904-912

2023

Volltextzugriff (PDF)

Atorvastatin lowers serum calcium levels in lithium-users: results from a randomized controlled trial

BMC endocrine disorders, 2022-09, Vol.22 (1), p.1-238, Article 238

2022

Volltextzugriff (PDF)

Subclinical hypothyroidism and the risk of cancer incidence and cancer mortality: a systematic review

BMC endocrine disorders, 2020-06, Vol.20 (1), p.83-10, Article 83

2020

Volltextzugriff (PDF)

The Combination of DPP-4 Inhibitors Versus Sulfonylureas with Metformin After Failure of First-line Treatment in the Risk for Major Cardiovascular Events and Death

Canadian journal of diabetes, 2015-10, Vol.39 (5), p.383-389

2015

Volltextzugriff (PDF)

188-LB: The Association between Glycemic Control during Hospitalization and Risk of Adverse Events: A Retrospective Cohort Study

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Corrigendum to “A Case of Severe Acute Kidney Injury Exacerbated by Canagliflozin in a Patient with Type 2 Diabetes”

Case reports in endocrinology, 2021, Vol.2021, p.7320217-1

2021

Volltextzugriff (PDF)

A Case of Severe Acute Kidney Injury Exacerbated by Canagliflozin in a Patient with Type 2 Diabetes

Case reports in endocrinology, 2019-01, Vol.2019 (2019), p.1-4

2019

Volltextzugriff (PDF)

An Assessment of the Shared Allelic Architecture between Type II Diabetes and Prostate Cancer

Cancer epidemiology, biomarkers & prevention, 2013-08, Vol.22 (8), p.1473-1475

2013

Volltextzugriff (PDF)

The association between glycaemic control during hospitalization and risk of adverse events: A retrospective cohort study

Endocrinology, diabetes & metabolism, 2021-07, Vol.4 (3), p.e00268-n/a

2021

Volltextzugriff (PDF)

Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study

BMJ (Online), 2018-03, Vol.360, p.k872

2018

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(49)
Dissertationen
(1)

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(36)
Science & Technology
(36)
Humans
(26)
Diabetes
(23)
Diabetes Mellitus
(19)
Endocrinology & Metabolism
(19)
Male
(16)
Diabetes Mellitus, Type 2 - Drug Therapy
(13)
Female
(12)
Aged
(10)
Middle Aged
(10)
Cohort Studies
(9)
Patients
(9)
Population Studies
(9)
Cohort Analysis
(8)
Hypoglycemic Agents - Adverse Effects
(8)
Risk Factors
(8)
Health Risk Assessment
(7)
Hypoglycemia
(7)
Myocardial Infarction
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study

Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events

Comparative risk of infection of medications used for type 2 diabetes

The association of long‐acting insulin analogue use versus neutral protamine Hagedorn insulin use and the risk of major adverse cardiovascular events among individuals with type 2 diabetes: A population‐based cohort study

Use of dipeptidyl peptidase-4 inhibitors and new-onset rheumatoid arthritis in patients with type 2 diabetes

Comparative cardiovascular and hypoglycaemic safety of glimepiride in type 2 diabetes: A population‐based cohort study

Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Below-Knee Amputation: A Multicenter Observational Study

1386-P: Dipeptidyl Peptidase-4 Inhibitors and the Risk of Skin Cancer among Patients with Type 2 Diabetes—Population-Based Cohort Study

SGLT‐2 inhibitors and the risk of hospitalization for community‐acquired pneumonia: A population‐based cohort study

A systematic review and meta-analysis comparing outcomes between using subcutaneous insulin and continuous insulin infusion in managing adult patients with diabetic ketoacidosis

268-OR: The Combined Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists on the Risk of Cardiovascular Events among Patients with Type 2 Diabetes

Long‐term clinical outcomes of oral antidiabetic drugs as fixed‐dose combinations: A nationwide retrospective cohort study

Occupation as a gendered-role and outcome in systemic sclerosis

Levothyroxine and the risk of adverse pregnancy outcomes in women with subclinical hypothyroidism: a systematic review and meta-analysis

Metformin and Cancer: Solutions to a Real-World Evidence Failure

Atorvastatin lowers serum calcium levels in lithium-users: results from a randomized controlled trial

Subclinical hypothyroidism and the risk of cancer incidence and cancer mortality: a systematic review

The Combination of DPP-4 Inhibitors Versus Sulfonylureas with Metformin After Failure of First-line Treatment in the Risk for Major Cardiovascular Events and Death

188-LB: The Association between Glycemic Control during Hospitalization and Risk of Adverse Events: A Retrospective Cohort Study

Corrigendum to “A Case of Severe Acute Kidney Injury Exacerbated by Canagliflozin in a Patient with Type 2 Diabetes”

A Case of Severe Acute Kidney Injury Exacerbated by Canagliflozin in a Patient with Type 2 Diabetes

An Assessment of the Shared Allelic Architecture between Type II Diabetes and Prostate Cancer

The association between glycaemic control during hospitalization and risk of adverse events: A retrospective cohort study

Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study

Suchergebnisse filtern